Stool test for colorectal cancer screening: What is going on?

Surgical Oncology

Volumn 16, Issue , 2007, Pages 43-45

  Bonanno, Elena ^a   Rulli, Francesco ^a   Galatà, Gabriele ^a   Pucci, Sabina ^a   Sesti, Fabiola ^a   Maria Farinon, Attilio ^a   Giusto Spagnoli, Luigi ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Colorectal cancer stool test

Indexed keywords

CLUSTERIN; DNA;

ADENOMA; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SCREENING; CANCER STAGING; CANCER THERAPY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; FECES ANALYSIS; HUMAN; INCIDENCE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; TUMOR LOCALIZATION;

COLORECTAL NEOPLASMS; DNA, NEOPLASM; FECES; HUMANS; MASS SCREENING; OCCULT BLOOD; SENSITIVITY AND SPECIFICITY;

EID: 36649011631     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2007.10.034     Document Type: Review

References (7)

1. Ransohoff D.F., and Lang C.A. Screening for colorectal cancer with the fecal occult blood test: a background paper. Annals of Internal Medicine 126 (1997) 811-822
2. Summerton C., Longlands M., Wiener K., and Shreeve D. Faecal calprotectin: a marker of inflammation throughout the intestinal tract. European Journal of Gastroenterology 14 8 (2002) 841-845
3. Song K., Fendrick A.M., and Ladabaum U. Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. Gastroenterology 126 (2004) 1270-1279
4. Limburg P.J., Devens M.E., Harrington J.J., Diehl N.N., Mahoney D.W., and Ahlquist D.A. Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia. The American journal of Gastroenterology 98 (2003) 2299-2305
5. Frattini M., Balestra D., Pilotti S., Bertario L., and Pierotti M.A. Tumor location and detection of k-ras mutations in stool from colorectal cancer patients. Journal of the National Cancer Institute 95 (2003) 72-73
6. Puig P., Urgell E., Capella G., Sancho F.J., Pujol J., Boadas J., et al. A highly sensitive method for K-ras mutation detection is useful in diagnosis of gastrointestinal cancer. International Journal of Cancer 85 (2000) 73-77
7. Pucci S., Bonanno E., Pichiorri F., Angeloni C., and Spagnoli L.G. Modulation of different clusterin isoforms in human colon tumorigenesis. Oncogene 23 (2004) 2298-2304